Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Confronting the shortcomings of covid-19 vaccination will help us in future pandemics.

Vanderslott S., (2025), BMJ, 388

Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men.

Firth C. et al, (2025), Vaccine, 54

Artificial intelligence for modelling infectious disease epidemics.

Kraemer MUG. et al, (2025), Nature, 638, 623 - 635

Effective altruism, technoscience and the making of philanthropic value

Taillandier A. et al, (2025), Economy and Society

Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy.

Kantor J. et al, (2024), BMJ Open, 14

Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial.

Patrick-Smith M. et al, (2024), Vaccine, 42

Pandemic Preparedness: Why Humanities and Social Sciences Matter

FRAMPTON S. et al, (2024), Frontiers in Public Health

Examining the role of community champions to promote vaccine uptake in under-served communities in the United Kingdom: Lessons from the COVID-19 pandemic

Vanderslott S. et al, (2024), SSM - Qualitative Research in Health, 5

Strengthening life-course immunisation in migrant populations: access, equity, and inclusion

Knights F. et al, (2024), The Lancet Regional Health - Europe, 41

Identifying characteristics that enable resilient immunisation programmes: a scoping review.

Baxter L. et al, (2024), BMJ Open, 14

Identifying factors that can be used to assess a country's readiness to deploy a new vaccine or improve uptake of an underutilised vaccine: a scoping review.

Bhatt A. et al, (2024), BMJ Open, 14

Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media.

Ruggeri K. et al, (2024), BMJ, 384

Making the most of big qualitative datasets: a living systematic review of analysis methods.

Chandrasekar A. et al, (2024), Front Big Data, 7

Pandemic preparedness: why humanities and social sciences matter.

Frampton S. et al, (2024), Front Public Health, 12

Political and Community Logics of Emergent Disease Vaccine Deployment Anthropological Insights from DRC, Uganda and Tanzania

Lees S. et al, (2024), Anthropologica, 66

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.

Thomas TM. et al, (2023), Hum Vaccin Immunother, 19

The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public.

Kantor J. et al, (2023), BMJ Open, 13

Online on the frontline: A longitudinal social media analysis of UK healthcare workers' attitudes to COVID-19 vaccines using the 5C framework.

Déom N. et al, (2023), Soc Sci Med, 339

Representation of ethnic and racial minority groups in European vaccine trials: a quantitative analysis of clinical trials registries

TANNER R. et al, (2023), BMJ Public Health

Motivations for paediatric vaccine trial participation.

Hillson K. et al, (2023), Trials, 24

Load More